10 Oversold Stocks to Buy Now

8. GoodRx Holdings Inc. (NASDAQ:GDRX)

3-Month Decline as of January 7: 33.82%

Average Upside Potential as of January 7: 71.82%

Number of Hedge Fund Holders: 21

GoodRx Holdings Inc. (NASDAQ:GDRX) is one of the oversold stocks to buy now. On January 5, Bank of America analyst Allen Lutz lowered the firm’s price target on GoodRx to $2.60 from $3 and kept an Underperform rating on the shares. For the broader drug distributor sector, however, the firm remained positive heading into 2026 and adjusted its price targets to align with recent changes in valuation multiples across the peer group.

Additionally, Morgan Stanley reduced its price target for GoodRx from $5 to $4 while maintaining an Equal Weight rating on December 18. In a 2026 outlook for the Healthcare Services sector, the firm noted that while healthcare tech and providers offer an attractive backdrop for alpha-generation, the managed care segment continues to struggle.

On December 8, Barclays initiated coverage of GoodRx with an Underweight rating and a $3 price target. While the firm established a Neutral outlook on the broader US healthcare tech and distribution industry, it expressed the most optimism toward drug distributors. In contrast, Barclays maintained a more cautious and mixed perspective on the dental and healthcare IT sub-sectors.

GoodRx Holdings Inc. (NASDAQ:GDRX), together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the US.